SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO
CYTO 0.3000.0%Dec 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Susan Saline who wrote (7839)4/10/2000 11:03:00 AM
From: Bill Ounce  Read Replies (2) of 8116
 
Long term, a secondary during a hot market could be a good thing for the company. If the money raised is well invested, the company can do really well. But, it it's just used for executive options packages, it will hurt shareholders long term.

Short term, it should hurt shareholders. If the market values the pie at $8/slice adding slices should reduce the price/slice.

CYTO does appear to be moving with the sector currently, but I've seen some Internet companies break with their sector after secondary offerings.

I really like CYTO, but some of the cautions raised itulip.com apply. (Not that you should take that parody too seriously, but some stuff it says may be accurate.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext